Evidence map›Paper›PMID 36132088›Full record

Trial reportBioMed research international2022

Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial Based on the Theory of Planned Behavior.

Narges Mobasheri, Leila Ghahremani, Ebrahim Fallahzadeh Abarghooee, Jafar Hassanzadeh

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06121999 (13-Week Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06121999 nacompletednot on this mapstarted 2023, after this paper: background citation

13-Week Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated Steatosis (MASH) in Adults: A Randomized Control Trial

TypeinterventionalSponsorGrand Valley State UniversityRan2023 to 2024Enrolled24ConditionsMetabolic Associated-dysfunction Steatotic Liver Disease (MASLD), Metabolic Associated-dysfunction Steatohepatitis (MASH)ArmsStandard of care acceptance-based behavioral weight loss program, Occupational therapy dietary and lifestyle modifications
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Narges MobasheriDepartment of Health Promotion and Education, Faculty of Health, Shiraz, Shiraz University of Medical Sciences, P.O. Box 75541-71536, Shiraz, Iran.ORCID https://orcid.org/0000-0002-3098-1810
Leila GhahremaniDepartment of Health Promotion and Education, Faculty of Health, Shiraz, Shiraz University of Medical Sciences, P.O. Box 75541-71536, Shiraz, Iran.ORCID https://orcid.org/0000-0001-5636-6974
Ebrahim Fallahzadeh AbarghooeeDepartment of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-5484-5178
Jafar HassanzadehDepartment of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-1055-1418
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, accounting for about 25% and 33% of the world's adult population and Iranians, respectively. There is currently no effective therapeutic agent available for the treatment of NAFLD. However, lifestyle modifications aimed at weight loss have been introduced as a cornerstone of NAFLD management. The aim of the present study was to evaluate the effect of educational intervention on lifestyle and anthropometric indices in patients with NAFLD. Methods: The randomized controlled clinical trial was performed on 87 overweight or obese patients with NAFLD, including intervention ( Results: After the intervention, a significant difference was found between the intervention and control groups, resulting in the increased mean scores of TPB constructs, decreased liver enzymes, and decreased degree of NAFLD ultrasound. In addition, the intervention group experienced more activity and healthy diet as compared with the control group. Anthropometric indices showed only a significant decrease in BMI in the intervention group ( Conclusions: TPB-based training, as compared with traditional training, is a more effective and cost-effective strategy for altering nutritional behavior and physical activity of patients with NAFLD.

Indexed as

Non-alcoholic Fatty Liver DiseaseAdultAlanine TransaminaseAspartate AminotransferasesHumansIranLife StyleLiverAlanine TransaminaseAspartate Aminotransferases

Identifiers

PMID36132088
PMCPMC9484896
OpenAlexW4296579891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.